Switch from enfuvirtide to raltegravir in virologically suppressed HIV-1 infected patients: Effects on level of residual viremia and quality of life
To access this article, please choose from the options below
PII: S1386-6532(09)00463-6
doi:10.1016/j.jcv.2009.09.025
© 2009 Elsevier B.V. All rights reserved.
